Most people think about protein in one context — building muscle. But the research paints a much bigger picture. Protein intake has meaningful implications for how long you live, how well you age, your risk of chronic disease, and whether your later decades are functional or fragile. This blog breaks down what the evidence actually says, separates the myths from the mechanisms, and gives you clear, actionable targets.
Why Muscle Mass Is a Longevity Marker
Before diving into protein numbers, it helps to understand why muscle matters beyond aesthetics.
After the age of 50, the average person loses roughly 1% of their muscle mass per year. Strength declines even faster, at approximately 3% annually. Left unchecked, this accelerates to about 4% strength loss per year by the time someone reaches 75. This process is called sarcopenia, and it is one of the most significant yet underappreciated contributors to poor health outcomes in older adults.
The consequences are severe. Muscle loss increases the risk of falls and fractures. Individuals who experience fragility fractures face double the mortality risk compared to those who do not. Among those who suffer a hip fracture, 22 to 58% do not survive the following 12 months. These are not abstract statistics. They represent a very direct link between lean mass, physical resilience, and survival.
Protein is the primary nutritional driver of muscle tissue preservation and growth. Getting it right is not a bodybuilding concern. It is a longevity concern.
The Problem With the RDA
The Recommended Dietary Allowance (RDA) for protein is 0.8 grams per kilogram of body weight per day. This number is widely cited, and widely misunderstood. The RDA represents the minimum required to prevent deficiency in a sedentary population, not the amount needed for optimal health or body composition.
The methodology behind it also has significant limitations. The RDA was established primarily using nitrogen balance studies, a technique that consistently underestimates actual protein needs because of methodological constraints in how nitrogen losses are measured.
More recent research using stable isotope methods suggests that the optimal protein intake for most adults sits between 1.2 and 1.6 grams per kilogram of body weight per day. For older adults specifically, consuming at least 1.2 g/kg per day has been shown to prevent lean mass loss and reduce frailty risk by as much as 30% compared to lower intakes. For those engaged in regular resistance training, 1.6 g/kg per day maximises lean mass gains, producing roughly 27% greater increases in muscle compared to intakes at the lower end of the range.
For practical application, protein targets should ideally be based on lean body mass or an adjusted goal body weight rather than total body weight. This is especially relevant for individuals carrying excess body fat, where basing targets on total weight can lead to inflated and unrealistic numbers.
Does Protein Cause Cancer or Shorten Your Life?
This is where the conversation gets complicated, because a frequently cited study did find an association between high protein intake and increased mortality. Middle-aged adults consuming protein at 20% or more of total daily calories were found to be 75% more likely to die from any cause and four times more likely to die from cancer compared to those on lower protein diets.
That sounds alarming. But context matters significantly here.
When researchers control for confounding lifestyle variables such as obesity, smoking, heavy alcohol consumption, and physical inactivity, the elevated risks largely disappear. In other words, the association between high protein and mortality was not independent. It was driven by the fact that people eating high amounts of poor-quality animal protein were also more likely to engage in other health-damaging behaviours. Among healthy, physically active individuals without these confounders, high protein intake does not show the same association with increased mortality.
This distinction is important for interpreting the research correctly. Observational data showing a correlation between two variables does not establish that one causes the other, especially when the population studied has multiple overlapping risk factors.
The IGF-1 and mTOR Conversation
The biological concern often raised about high protein intake centres on two pathways: IGF-1 (insulin-like growth factor 1) and mTOR (mechanistic target of rapamycin). Both are activated by protein intake and play a role in cellular growth and proliferation. In theory, chronically elevated IGF-1 and mTOR activity could accelerate cellular aging and increase cancer risk.
The nuance that is frequently missed in popular discussions of this topic is the role of exercise. Physical activity fundamentally changes how these pathways are used by the body. When you exercise regularly, elevated IGF-1 and mTOR activity is directed toward tissue repair, muscle synthesis, and neurological health rather than uncontrolled cellular proliferation. The same growth signals that are potentially concerning in a sedentary context become beneficial and appropriate in an active one.
This is why looking at protein intake in isolation, without accounting for physical activity levels, produces misleading conclusions. The combination of adequate protein and regular resistance training is associated with better health outcomes, not worse ones.
What Protein Quality Actually Means
Not all protein sources are equal when it comes to stimulating muscle protein synthesis. Quality is determined by three main factors: digestibility, amino acid completeness, and leucine content.
Leucine is a branched-chain amino acid and the primary molecular trigger for muscle protein synthesis. It activates the mTOR pathway directly. Research indicates that a leucine threshold of approximately 2 to 3 grams per meal must be met to meaningfully stimulate muscle protein synthesis. This threshold can typically be achieved with around 20 grams of a high-quality protein source such as whey.
Critically, leucine only initiates the process. All essential amino acids are required to sustain muscle protein synthesis for the full 4 to 6 hour post-meal window. Sources that are rich in leucine but incomplete in their essential amino acid profile will trigger the process but not sustain it effectively.
Animal-based proteins generally outperform plant-based proteins on both digestibility and leucine content, which is why they tend to produce greater muscle protein synthesis per gram. This does not mean plant-based diets cannot meet protein needs. They can, but they typically require higher total intake, greater variety of sources, and in some cases, the use of protein concentrates or isolates to compensate for lower bioavailability and amino acid completeness.
Aging also raises the leucine threshold, meaning older adults need more leucine per meal to achieve the same anabolic response as younger individuals. Regular exercise improves muscle sensitivity to leucine and partially offsets this age-related resistance.
Timing, Distribution, and the Anabolic Window
The question of protein timing has been debated extensively, but the practical conclusions are fairly clear. Spreading protein intake across 3 to 4 meals per day, with each meal providing at least 20 to 25 grams of high-quality protein, is likely optimal for maximising daily muscle protein synthesis. Older adults may benefit from targeting 20 to 30 grams per meal given their higher leucine threshold.
The idea that the body can only use 20 to 25 grams of protein in a single sitting has been convincingly challenged by recent research. Work from Jorn Trommelen group demonstrated that consuming 100 grams of protein after a single exercise session produced a robust and sustained anabolic response, not a wasted surplus. The body processes larger doses more slowly, extending the period of elevated muscle protein synthesis rather than hitting a hard ceiling.
The practical implication is that the anabolic window post-exercise is wider than once believed. Whether you eat protein immediately before or after training does not appear to matter significantly for outcomes. Total daily protein intake is the variable that most reliably predicts results over time. Distribution and timing are secondary optimisations, not primary ones.
Pre-sleep protein intake is worth a mention here. Consuming a protein source before bed, particularly a slower-digesting option like casein, has been shown to support overnight muscle protein synthesis. This is most relevant for athletes in hard training blocks and older adults trying to preserve or rebuild lean mass.
Is High Protein Safe for the Kidneys?
The concern that high protein intake damages healthy kidneys is one of the most persistent myths in nutrition. Current evidence does not support this claim in individuals without pre-existing kidney disease. High protein intake does increase the filtration load on the kidneys, but healthy kidneys adapt to this load without adverse effects. The confusion likely arose from observations in individuals who already had compromised kidney function, where protein restriction is genuinely indicated. In healthy people, the evidence does not show harm.
Putting It Together: Practical Targets
For most healthy adults, a daily protein intake of 1.2 to 1.6 g/kg of body weight covers both muscle preservation and longevity-relevant outcomes. Those engaged in regular resistance training, actively trying to reduce body fat while preserving muscle, or over the age of 60 should aim toward the upper end of this range or slightly above it. Calculate the target based on lean body mass or an adjusted goal weight rather than total body weight if body fat is above healthy ranges.
Distribute intake across meals rather than concentrating it in one or two large servings, aim for a leucine-rich source at each meal, consider a protein feeding before sleep if muscle gain or retention is a priority, and pair intake with a consistent resistance training programme. The combination of these habits does not just support a better physique. The evidence suggests it supports a longer, more functional life.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC3597289/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3424729/
https://pubmed.ncbi.nlm.nih.gov/38118410/
